News
Indian pharmaceutical companies are preparing to launch generic versions of Novo Nordisk's weight-loss drug, semaglutide, potentially reducing its price by up to 80%.
Eli Lilly and Company is gearing up for its second quarter earnings report this Thursday, before the market opens. The pharmaceutical giant has witnessed significant revenue boosts from its ...
I can disclose the showman's vision is materialising, courtesy of discreet British brothers who already own 'a collection of ...
Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...
Discover the top celebrity weight loss transformations of 2025 and the inspiring journeys behind their success ...
A CELEBRITY doctor has defended sleep-deprived mums who are turning to fat jabs to lose weight. Dr Punam Krishan, who starred ...
Lawsuits from at least 26 patients have been filed in Marion County against Eli Lilly and Co. for its marketing of the drugs ...
FAT jab users will go to dangerous sellers if the Mounjaro rollout is botched by the NHS, drugs bosses warn. Just eight of 42 health service boards offer the weight-loss injection after a launch ...
Downtown Dubai’s The Banc is changing the dining game with a brand-new menu made for guests on Ozempic, Mounjaro, and Wegovy. These prescribed meds, originally meant for type 2 diabetes, are now also ...
As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...
Thousands of patients desperate to access the “King Kong” of weight loss jabs are facing a postcode lottery, research reveals ...
The updated standard replaces three previous guidelines and reflects the latest thinking on tackling obesity through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results